These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 19098687

  • 21. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Bérubé R, Bélanger P, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
    [Abstract] [Full Text] [Related]

  • 22. Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
    Kloosterboer HJ, Löfgren L, von Schoulz E, von Schoultz B, Verheul HA.
    Reprod Sci; 2007 Feb; 14(2):151-9. PubMed ID: 17636226
    [Abstract] [Full Text] [Related]

  • 23. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [Abstract] [Full Text] [Related]

  • 24. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D, Suchecka-Rachoń K, Hak Ł, Myśliwska J.
    Menopause; 2006 Jun; 13(5):840-5. PubMed ID: 16894332
    [Abstract] [Full Text] [Related]

  • 25. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y, Labrie F, Gonthier R, Simard JN, Bergeron D, Martel C, Vaillancourt M, Montesino M, Lavoie L, Archer DF, Balser J, Moyneur E, other participating Members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women.
    Wren BG, Day RO, McLachlan AJ, Williams KM.
    Climacteric; 2003 Jun; 6(2):104-11. PubMed ID: 12841880
    [Abstract] [Full Text] [Related]

  • 27. Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA.
    Ke Y, Gonthier R, Simard JN, Archer D, Lavoie L, Martel C, Vaillancourt M, Labrie F.
    Horm Mol Biol Clin Investig; 2015 Dec; 24(3):117-29. PubMed ID: 26509785
    [Abstract] [Full Text] [Related]

  • 28. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
    Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL.
    J Steroid Biochem Mol Biol; 2013 Nov; 138():359-67. PubMed ID: 23954500
    [Abstract] [Full Text] [Related]

  • 29. Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals.
    Mueller A, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Dittrich R.
    Horm Metab Res; 2006 Mar; 38(3):183-7. PubMed ID: 16673210
    [Abstract] [Full Text] [Related]

  • 30. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
    Shah S, Bell RJ, Savage G, Goldstat R, Papalia MA, Kulkarni J, Donath S, Davis SR.
    Menopause; 2006 Mar; 13(4):600-8. PubMed ID: 16837882
    [Abstract] [Full Text] [Related]

  • 31. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.
    Morton TL, Gattermeir DJ, Petersen CA, Day WW, Schumacher RJ.
    J Clin Pharmacol; 2009 Sep; 49(9):1037-46. PubMed ID: 19628730
    [Abstract] [Full Text] [Related]

  • 32. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [Abstract] [Full Text] [Related]

  • 33. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Jun; 16(5):907-22. PubMed ID: 19436225
    [Abstract] [Full Text] [Related]

  • 34. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G.
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):716-24. PubMed ID: 23488643
    [Abstract] [Full Text] [Related]

  • 35. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.
    van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL.
    J Rheumatol; 1998 Feb; 25(2):285-9. PubMed ID: 9489820
    [Abstract] [Full Text] [Related]

  • 36. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Feb; 16(5):923-31. PubMed ID: 19424093
    [Abstract] [Full Text] [Related]

  • 37. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women.
    Stanczyk FZ, Chaikittisilpa S, Sriprasert I, Rafatnia A, Nadadur M, Mishell DR.
    Climacteric; 2019 Apr; 22(2):169-174. PubMed ID: 30612472
    [Abstract] [Full Text] [Related]

  • 38. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.
    Mortola JF, Yen SS.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):696-704. PubMed ID: 2144295
    [Abstract] [Full Text] [Related]

  • 39. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
    Chan MF, Dowsett M, Folkerd E, Wareham N, Luben R, Welch A, Bingham S, Khaw KT.
    Menopause; 2008 Sep; 15(2):332-9. PubMed ID: 17667152
    [Abstract] [Full Text] [Related]

  • 40. Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    N Engl J Med; 1999 Sep 30; 341(14):1013-20. PubMed ID: 10502590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.